Roche’s Tarceva Edges Out Iressa, Alimta In The Philippines As Focus On Specialty Drugs Pays Off
This article was originally published in PharmAsia News
Executive Summary
Swiss-based Roche finds a way to boost Tarceva sales in the Philippines without access to the public health system, showing another niche in its specialty drug sales in emerging markets.